Tarsus Pharmaceuticals (TARS) Debt Ratio (2022 - 2026)

Tarsus Pharmaceuticals' Debt Ratio history runs 5 years deep, the most recent figure standing at 0.12 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 13.1% year-over-year to 0.12 in Q1 2026; TTM through Mar 2026 was 0.12, a 13.1% decrease from a year earlier, with the FY2025 full-year figure at 0.13, down 32.39% from the prior year.
• Debt Ratio retreated to 0.12 in Q1 2026 per TARS's latest filing, from 0.13 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.19 in Q4 2024 and bottomed at 0.08 in Q2 2022.
• The 5-year median for Debt Ratio is 0.12 (2026), against an average of 0.13.
• Across the five-year window, Debt Ratio jumped 72.12% in 2024 and tumbled 32.39% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.09 in 2022, then surged by 31.69% to 0.11 in 2023, then soared by 69.68% to 0.19 in 2024, then tumbled by 32.39% to 0.13 in 2025, then retreated by 3.05% to 0.12 in 2026.
• Per Business Quant, the three latest TARS Debt Ratio figures stand at 0.12 (Q1 2026), 0.13 (Q4 2025), and 0.14 (Q3 2025).